CordLife operates the most extensive network of multinational cord blood banks in Asia, with 6 labs in 6 countries as of 2011.
Labs and Locations
CordLife India announced
in April 2013 that they are the only bank in India that not only separates stem cells from cord blood and cord tissue, but also cultures them in the lab to grow an "expanded" cell count for therapeutic options.
CordLife India is a majority-owned subsidiary of CordLife Limited, a company listed on the Australian Securities Exchange. CordLife Limited owns and operates 3 state-of-the-art stem cell processing and cryopreservation facilities in India, Indonesia and the Philippines. They are affiliated with the CordLife Group that owns laboratories in Singapore, Hong Kong, and China.
CordLife India is the first bank
in India to process cord blood with the fully automated and sterile Sepax processing system from Biosafe